<DOC>
	<DOCNO>NCT00572975</DOCNO>
	<brief_summary>*The purpose study develop accurate , reliable , specific acceptable alternative clinical test 72-hour stool diet collection quantify fat malabsorption people CF pancreatic insufficiency .</brief_summary>
	<brief_title>Malabsorption Blood Test : Toward Novel Approach Quantify Steatorrhea</brief_title>
	<detailed_description>- Nine subject CF recruit complete MBT two separate occasion , different dos pancreatic enzyme - At MBT visit , subject receive specific enzyme dose drink test meal ( shake ) - Fat absorption maximize enzymes take shake . - If subject usually receive brand pancreatic enzymes different Creon , dose convert equivalent dose Creon 20 study . Prior study visit subject require : - Eat usual diet 2 day prior MBT - Refrain consume alcohol dairy product 24 hour prior MBT - Refrain non-routine physical exercise 20 hour prior MBT - Adhere 12-hour fast prior MBT ( 8 PM previous night ) - Can drink water 8:00 PM night test 2:00 AM day test - At visit 1 2 , blood sample obtain hourly interval period eight hour . - Samples analyze PA , HA Triglyceride concentration . - Patients permit ingest non-caloric non-caffeinated beverage . - At hour 6 , patient provide 1000 Kcal , low fat ( 12 gram fat ) lunch meal .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Exocrine Pancreatic Insufficiency</mesh_term>
	<mesh_term>Malabsorption Syndromes</mesh_term>
	<mesh_term>Steatorrhea</mesh_term>
	<criteria>Subjects cystic fibrosis pancreatic insufficiency ( n=9 ) , 8 year age old , usual state good health eligible participate Aim . Subjects screen genotype history pancreatic insufficiency ( PI ) . PI confirm measurement fecal elastase 1 &lt; 200 mg/g stool . Subjects ineligible FEV1 % predict &lt; 40 % , history fibrosing colonopathy significant bowel resection ( &gt; 10 cm ) exception routine , uncomplicated appendectomy . Subjects diabetes mellitus disorder associate alter energy metabolism ( i.e . hypothyroidism ) , major illness affect gastrointestinal tract , eligible study . Subjects significant liver disease , significant developmental delay also exclude . Subjects exclude food allergy related component experimental shake ( i.e. , soy chocolate ) stool marker , carmine red . Subjects pregnant eligible . Subjects history intolerance allergy Creon 20 exclude study .</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>New diagnostic test Cystic Fibrosis .</keyword>
</DOC>